2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with azd 1152-hqpa in 1 studies
| Studies (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Trials (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Recent Studies (post-2010) (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Studies (azd 1152-hqpa) | Trials (azd 1152-hqpa) | Recent Studies (post-2010) (azd 1152-hqpa) |
|---|---|---|---|---|---|
| 85 | 0 | 62 | 31 | 1 | 27 |
| Protein | Taxonomy | 2-(4-morpholinoanilino)-6-cyclohexylaminopurine (IC50) | azd 1152-hqpa (IC50) |
|---|---|---|---|
| Aurora kinase A | Homo sapiens (human) | 1.393 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.1 | |
| Aurora kinase B | Homo sapiens (human) | 0.0028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SW; Hao, SY; Li, WB; Qiao, XP; Wang, ZX; Xu, Y; Zhang, XJ | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and azd 1152-hqpa
| Article | Year |
|---|---|
Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.
Topics: Apoptosis; Aurora Kinase A; Aurora Kinase B; bcl-2-Associated X Protein; Binding Sites; Cell Line, Tumor; Drug Design; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; Structure-Activity Relationship | 2020 |